Click for best price

Molecular DiagnosticsInfectious Disease Testing Market Size, Share 2022

Market Analysis and Insights: Global Molecular DiagnosticsInfectious Disease Testing Market

The global Molecular DiagnosticsInfectious Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular DiagnosticsInfectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular DiagnosticsInfectious Disease Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular DiagnosticsInfectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular DiagnosticsInfectious Disease Testing market.

Global Molecular DiagnosticsInfectious Disease Testing Scope and Market Size

Market Analysis and Insights: Global Molecular Diagnostics in Infectious Disease Testing Market

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.

The global Molecular Diagnostics in Infectious Disease Testing market size is projected to reach US$ million by 2030, from US$ million in 2022, at a CAGR of % during 2023-2030.

North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics in Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics in Infectious Disease Testing market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics in Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics in Infectious Disease Testing market.

Global Molecular Diagnostics in Infectious Disease Testing Scope and Market Size

Molecular Diagnostics in Infectious Disease Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics in Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2030.

Segment by Type

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Microarrays

Next-Generation Sequencing (NGS)

Hybridization

Others

Segment by Application

Hospitals

Clinics

Academic Institutes

Laboratories

Others

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Abbott

BioMerieux

Thermo Fisher Scientific

Roche

Siemens

Veridex

Luminex

GenMark Diagnostics

Qiagen

Genomix Biotech

BioTheranostics

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Molecular DiagnosticsInfectious Disease Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Molecular DiagnosticsInfectious Disease Testing, with price, sales, revenue, and global market share of Molecular DiagnosticsInfectious Disease Testing from 2019 to 2022.

Chapter 3, the Molecular DiagnosticsInfectious Disease Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Molecular DiagnosticsInfectious Disease Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Molecular DiagnosticsInfectious Disease Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular DiagnosticsInfectious Disease Testing.

Chapter 13, 14, and 15, to describe Molecular DiagnosticsInfectious Disease Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Molecular DiagnosticsInfectious Disease Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2023
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	90 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2017-2030)
2.2 Molecular Diagnostics in Infectious Disease Testing Growth Trends by Region
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Region (2017-2023)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2023-2030)
2.3 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2017-2023)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2017-2023)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2022
3.5 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2017-2023)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2023-2030)
5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2017-2023)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2030)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2030)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2030)
8.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023)
8.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2030)
9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023)
9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2030)
10.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023)
10.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.2.5 BD Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.3.5 BioMerieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.5.5 Roche Recent Development
11.6 Siemens
11.6.1 Siemens Company Detail
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.6.5 Siemens Recent Development
11.7 Veridex
11.7.1 Veridex Company Detail
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Detail
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.10.5 Qiagen Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Detail
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Detail
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
11.12.5 BioTheranostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2022 VS 2030
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Key Players of Microarrays
Table 5. Key Players of Next-Generation Sequencing (NGS)
Table 6. Key Players of Hybridization
Table 7. Key Players of Others
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2017 VS 2022 VS 2030
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2030
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2023) & (US$ Million)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2017-2023)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2023-2030)
Table 14. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 15. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 16. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 17. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2017-2023) & (US$ Million)
Table 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2017-2023)
Table 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
Table 21. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 25. Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2023) & (US$ Million)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2023)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2023-2030)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2023) & (US$ Million)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2017-2023)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2023-2030)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023) & (US$ Million)
Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030) & (US$ Million)
Table 37. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023) & (US$ Million)
Table 38. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2023) & (US$ Million)
Table 40. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2023-2030) & (US$ Million)
Table 41. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023) & (US$ Million)
Table 42. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030) & (US$ Million)
Table 43. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2023) & (US$ Million)
Table 44. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2030) & (US$ Million)
Table 45. Abbott Company Detail
Table 46. Abbott Business Overview
Table 47. Abbott Molecular Diagnostics in Infectious Disease Testing Product
Table 48. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 49. Abbott Recent Development
Table 50. BD Company Detail
Table 51. BD Business Overview
Table 52. BD Molecular Diagnostics in Infectious Disease Testing Product
Table 53. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 54. BD Recent Development
Table 55. BioMerieux Company Detail
Table 56. BioMerieux Business Overview
Table 57. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
Table 58. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 59. BioMerieux Recent Development
Table 60. Thermo Fisher Scientific Company Detail
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
Table 63. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. Roche Company Detail
Table 66. Roche Business Overview
Table 67. Roche Molecular Diagnostics in Infectious Disease Testing Product
Table 68. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 69. Roche Recent Development
Table 70. Siemens Company Detail
Table 71. Siemens Business Overview
Table 72. Siemens Molecular Diagnostics in Infectious Disease Testing Product
Table 73. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 74. Siemens Recent Development
Table 75. Veridex Company Detail
Table 76. Veridex Business Overview
Table 77. Veridex Molecular Diagnostics in Infectious Disease Testing Product
Table 78. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 79. Veridex Recent Development
Table 80. Luminex Company Detail
Table 81. Luminex Business Overview
Table 82. Luminex Molecular Diagnostics in Infectious Disease Testing Product
Table 83. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 84. Luminex Recent Development
Table 85. GenMark Diagnostics Company Detail
Table 86. GenMark Diagnostics Business Overview
Table 87. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
Table 88. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 89. GenMark Diagnostics Recent Development
Table 90. Qiagen Company Detail
Table 91. Qiagen Business Overview
Table 92. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
Table 93. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 94. Qiagen Recent Development
Table 95. Genomix Biotech Company Detail
Table 96. Genomix Biotech Business Overview
Table 97. Genomix Biotech Molecular Diagnostics in Infectious Disease TestingProduct
Table 98. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 99. Genomix Biotech Recent Development
Table 100. BioTheranostics Company Detail
Table 101. BioTheranostics Business Overview
Table 102. BioTheranostics Molecular Diagnostics in Infectious Disease TestingProduct
Table 103. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023) & (US$ Million)
Table 104. BioTheranostics Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2022 VS 2030
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2022 & 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2030
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2022 VS 2030
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region: 2022 VS 2030
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2022
Figure 19. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2022
Figure 21. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 22. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2030)
Figure 23. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 24. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 25. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 26. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2030)
Figure 27. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 28. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 29. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 30. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 31. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 32. Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 33. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 34. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2017-2030)
Figure 35. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 36. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 37. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 38. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 39. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 40. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 41. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 42. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2030)
Figure 43. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 44. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 45. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 46. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2030)
Figure 47. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 48. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 50. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 51. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 53. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 54. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 55. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 56. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 57. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 58. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 59. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 60. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2023